UCB’s Epilepsy Drug Briviact (brivaracetam) Gains Approval in Japan for Focal Onset Seizures | 2024 | iPharmaCenter
top of page
Briviact (brivaracetam) has been approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) as both a monotherapy and...
Takeda Announces Approval of Livtencity in Japan for Resistant Post-Transplant Cytomegalovirus (CMV) Infection/Disease
Takeda announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Livtencity (maribavir) for the...
Japan Drug Approvals | 日本の医薬品承認 | ニュース | 日本のニュース速報 | 健康管理 | 2024 | iPharmaCenter
Dupixent approved for chronic spontaneous urticaria Japan became the first country to approve Dupixent for chronic spontaneous urticaria...
Japan Drug Approvals | 2023 | MHLW | PMDA | iPharmaCenter
Bimzelx was approved in Japan for Psoriatic Arthritis, Non-radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis Bimzelx...
Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System
Mar 12. 2021 Takeda’s New Drug Application was submitted for MHLW in Japan for Hereditary Angioedema Attacks Takeda announced that it...
Lynparza was approved for three more indications in Japan
AstraZeneca and Merck announced that Lynparza (olaparib) was approved for three more indications in Japan. The three new cancer...
Merck’s Keytruda received one more indication and dosage form approval in Japan
Merck has announced that it has received the approval of its anti-PD-1 therapy, Keytruda (pembrolizumab) for radically unresectable,...
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients
Gilead has announced top-line Phase 3 trial results of remdesivir in patients with COVID-19. The drug is indicated in moderate COVID-19...
Astellas received approval for Xtandi in Japan for prostate cancer
Astellas announced that it had received approval from Japan Ministry of Health, Labour and Welfare (MHLW) for Xtandi (enzalutamide) for...
AstraZeneca's Lokelma approved in Japan
AstraZeneca has announced that it has received the approval for Lokelma (sodium zirconium cyclosilicate) in Japan. Japan's Ministry of...
bottom of page